GCM
TRIB

Goldman Capital Management’s Trinity Biotech TRIB Stock Holding History

Goldman Capital Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$235K Sell
307
-256
-45% -$198K 0.23% 23
2017
Q3 		$474K Sell
563
-80
-12% -$66.9K 0.45% 19
2017
Q2 		$579K Sell
643
-452
-41% -$384K 0.61% 20
2017
Q1 		$979K Sell
1,095
-653
-37% -$613K 0.94% 17
2016
Q4 		$1.81M Sell
1,748
-973
-36% -$1.01M 1.57% 10
2016
Q3 		$5.4M Sell
2,721
-50
-2% -$93.4K 4.34% 8
2016
Q2 		$4.71M Buy
2,771
+126
+5% +$213K 4.06% 9
2016
Q1 		$4.63M Buy
2,645
+59
+2% +$93.9K 3.5% 8
2015
Q4 		$4.56M Buy
2,586
+246
+11% +$436K 3.54% 8
2015
Q3 		$4.01M Buy
2,340
+569
+32% +$1.37M 2.87% 9
2015
Q2 		$4.8M Sell
1,771
-294
-14% -$764K 2.99% 9
2015
Q1 		$5.96M Hold
2,065
– – 3.48% 8
2014
Q4 		$5.42M Buy
2,065
+3
+0.1% +$7.76K 3% 8
2014
Q3 		$5.65M Buy
2,062
+31
+2% +$101K 2.83% 10
2014
Q2 		$7.02M Hold
2,031
– – 3.48% 7
2014
Q1 		$7.47M Sell
2,031
-49
-2% -$193K 4.04% 6
2013
Q4 		$5.83M Hold
2,080
– – 3.18% 10
2013
Q3 		$6.79M Sell
2,080
-207
-9% -$605K 4.48% 7
2013
Q2 		$5.78M Buy
+2,287
New +$5.69M 3.3% 8

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

Goldman Capital Management's TRIB Position: Q4 2017 in Review

Goldman Capital Management reduced its Trinity Biotech (TRIB) stake by 45% in Q4 2017, selling an estimated $198K and leaving 307 shares worth $235K. The position accounts for 0.23% of the portfolio, ranked #23.

Goldman Capital Management first reported a position in TRIB in Q2 2013 and has held it in 19 quarters since. The position peaked at $7.47M in Q1 2014. 47 funds tracked by Wall St. Rank hold TRIB as of Q4 2017.

  • Goldman Capital Management held 307 shares of Trinity Biotech worth $235K as of Q4 2017.
  • Goldman Capital Management sold 256 Trinity Biotech shares in Q4 2017, an estimated $198K.
  • Trinity Biotech made up 0.23% of Goldman Capital Management's portfolio in Q4 2017, its #23 holding.
  • Goldman Capital Management first reported a position in Trinity Biotech in Q2 2013 and has held it in 19 quarters since.
  • Goldman Capital Management's Trinity Biotech position peaked at $7.47M in Q1 2014.
  • 47 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2017.

Based on Goldman Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.